AASHIKA RAFANAN: Open Payments
NPI 1790457349 · OXNARD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$330 in 19 payments from 4 companies in 2025. Trend: 2023 $424 · 2024 $401 · 2025 $330
Food & beverage: $330
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 11 | $171 |
| Forte Bio-Pharma LLC | 4 | $76 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $69 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: Belbuca, PROLATE, JOURNAVX, XTAMPZA, RELISTOR.
Industry payments across CA — which companies pay providers there.
